Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2005 1
2007 1
2009 2
2010 3
2011 5
2012 1
2013 2
2014 4
2015 6
2016 7
2017 10
2018 8
2019 9
2020 11
2021 17
2022 7
2023 14
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

94 results

Results by year

Filters applied: . Clear all
Page 1
Rituximab and mycophenolate mofetil combination in patients with interstitial lung disease (EVER-ILD): a double-blind, randomised, placebo-controlled trial.
Mankikian J, Caille A, Reynaud-Gaubert M, Agier MS, Bermudez J, Bonniaud P, Borie R, Brillet PY, Cadranel J, Court-Fortune I, Crestani B, Debray MP, Gomez E, Gondouin A, Hirschi-Santelmo S, Israel-Biet D, Jouneau S, Juvin K, Leger J, Kerjouan M, Marquette CH, Naccache JM, Nunes H, Plantier L, Prevot G, Quetant S, Traclet J, Valentin V, Uzunhan Y, Wémeau-Stervinou L, Bejan-Angoulvant T, Cottin V, Marchand-Adam S; EVER-ILD investigators and the OrphaLung network. Mankikian J, et al. Eur Respir J. 2023 Jun 8;61(6):2202071. doi: 10.1183/13993003.02071-2022. Print 2023 Jun. Eur Respir J. 2023. PMID: 37230499 Free article. Clinical Trial.
The least-squares mean change from baseline to 6 months in FVC (% predicted) was +1.60 (se 1.13) in the rituximab+MMF group and -2.01 (se 1.17) in the placebo+MMF group (between-group difference 3.60, 95% CI 0.41-6.80; p=0.0273). PFS was better in the rituximab+MMF group ( …
The least-squares mean change from baseline to 6 months in FVC (% predicted) was +1.60 (se 1.13) in the rituximab+MMF group and -2.01 (se 1. …
Myopia and Near Work: A Systematic Review and Meta-Analysis.
Dutheil F, Oueslati T, Delamarre L, Castanon J, Maurin C, Chiambaretta F, Baker JS, Ugbolue UC, Zak M, Lakbar I, Pereira B, Navel V. Dutheil F, et al. Int J Environ Res Public Health. 2023 Jan 3;20(1):875. doi: 10.3390/ijerph20010875. Int J Environ Res Public Health. 2023. PMID: 36613196 Free PMC article. Review.
RESULTS: We included 78 studies, representing a total of 254,037 participants, aged from 6 to 39 years. The global prevalence of myopia in near work was 35% (95% CI: 30 to 41%), with a prevalence of 31% (95% CI: 26 to 37%) in children and 46% (95% CI: 30 to 6 …
RESULTS: We included 78 studies, representing a total of 254,037 participants, aged from 6 to 39 years. The global prevalence of myopia in n …
High-level burnout in physicians and nurses working in adult ICUs: a systematic review and meta-analysis.
Papazian L, Hraiech S, Loundou A, Herridge MS, Boyer L. Papazian L, et al. Intensive Care Med. 2023 Apr;49(4):387-400. doi: 10.1007/s00134-023-07025-8. Epub 2023 Mar 27. Intensive Care Med. 2023. PMID: 36971792 Free PMC article.
Combining 18 studies including 8187 ICU physicians, 3660 of them reported a high level of burnout (prevalence 0.41, range 0.15-0.71, 95% CI [0.33; 0.5], I(2) 97.6%, 95% CI [96.9%; 98.1%]). The heterogeneity can be at least in part explained by the definition of burn …
Combining 18 studies including 8187 ICU physicians, 3660 of them reported a high level of burnout (prevalence 0.41, range 0.15-0.71, 95% …
Effect of prone positioning on survival in adult patients receiving venovenous extracorporeal membrane oxygenation for acute respiratory distress syndrome: a systematic review and meta-analysis.
Papazian L, Schmidt M, Hajage D, Combes A, Petit M, Lebreton G, Rilinger J, Giani M, Le Breton C, Duburcq T, Jozwiak M, Wengenmayer T, Roux D, Parke R, Loundou A, Guervilly C, Boyer L. Papazian L, et al. Intensive Care Med. 2022 Mar;48(3):270-280. doi: 10.1007/s00134-021-06604-x. Epub 2022 Jan 17. Intensive Care Med. 2022. PMID: 35037993 Free PMC article.
PP was associated with a significant improvement in 28-day survival (503 survivors among 681 patients in the PP group [74%; 95% CI 71-77] vs. 450 survivors among 770 patients in the control group [58%, 95% CI 55-62]; RR 1.31 [95% CI 1.21-1.41]; I(2) 22% [95% …
PP was associated with a significant improvement in 28-day survival (503 survivors among 681 patients in the PP group [74%; 95% CI 71 …
[Alitretinoin: Toctino].
Berbis P. Berbis P. Ann Dermatol Venereol. 2010 Apr;137(4):329-33. doi: 10.1016/j.annder.2010.02.015. Epub 2010 Apr 9. Ann Dermatol Venereol. 2010. PMID: 20417372 Review. French. No abstract available.
Effect of non-invasive ventilation after extubation in critically ill patients with obesity in France: a multicentre, unblinded, pragmatic randomised clinical trial.
De Jong A, Bignon A, Stephan F, Godet T, Constantin JM, Asehnoune K, Sylvestre A, Sautillet J, Blondonnet R, Ferrandière M, Seguin P, Lasocki S, Rollé A, Fayolle PM, Muller L, Pardo E, Terzi N, Ramin S, Jung B, Abback PS, Guerci P, Sarton B, Rozé H, Dupuis C, Cousson J, Faucher M, Lemiale V, Cholley B, Chanques G, Belafia F, Huguet H, Futier E, Azoulay E, Molinari N, Jaber S; EXTUB-OBESE trial group. De Jong A, et al. Lancet Respir Med. 2023 Jun;11(6):530-539. doi: 10.1016/S2213-2600(22)00529-X. Epub 2023 Jan 21. Lancet Respir Med. 2023. PMID: 36693403 Clinical Trial.
Treatment failure occurred in 66 (13.5%) of 490 patients in the NIV group and in 130 (26.5%) of 491 patients in the oxygen-therapy group (relative risk 0.43; 95% CI 0.31-0.60, p<0.0001). Medical or surgical status did not modify the effect of NIV group on the treatment- …
Treatment failure occurred in 66 (13.5%) of 490 patients in the NIV group and in 130 (26.5%) of 491 patients in the oxygen-therapy group (re …
Inhaled nitric oxide in patients with acute respiratory distress syndrome caused by COVID-19: treatment modalities, clinical response, and outcomes.
Mekontso Dessap A, Papazian L, Schaller M, Nseir S, Megarbane B, Haudebourg L, Timsit JF, Teboul JL, Kuteifan K, Gainnier M, Slama M, Houeto P, Lecourt L, Mercat A, Vieillard-Baron A. Mekontso Dessap A, et al. Ann Intensive Care. 2023 Jun 27;13(1):57. doi: 10.1186/s13613-023-01150-9. Ann Intensive Care. 2023. PMID: 37368036 Free PMC article.
The latter showed significantly lower mortality than the other half (who remained ECMO eligible), including after confounder adjustment (adjusted OR: 0.23, 95% CI 0.06, 0.89, p = 0.03). CONCLUSIONS: Our study reports the benefits of iNO in improving arterial oxygenation in …
The latter showed significantly lower mortality than the other half (who remained ECMO eligible), including after confounder adjustment (adj …
Effects of evidence-based nursing in patients with stroke: A systematic review and meta-analysis.
Xue X, Zhang L, Zhen J, Zeng X. Xue X, et al. Nurse Educ Pract. 2024 Mar;76:103921. doi: 10.1016/j.nepr.2024.103921. Epub 2024 Feb 14. Nurse Educ Pract. 2024. PMID: 38395003 Free article. Review.
The risk of bias in included studies was assessed as low. The OR for cumulative death was 1.61 (95% CI: 0.68, 3.85; z = 1.08, P = 0.2811). The pooled SMD for SF-36 physical component scores was -0.06 (95% CI: -1.15, 0.04; z = -1.11, P = 0.2688). The SMD for SF-36 me …
The risk of bias in included studies was assessed as low. The OR for cumulative death was 1.61 (95% CI: 0.68, 3.85; z = 1.08, P = 0.2 …
Impact of Cilostazol Pharmacokinetics on the Development of Cardiovascular Side Effects in Patients with Cerebral Infarction.
Yokoyama T, Yamauchi S, Yamagata K, Kaneshiro Y, Urano Y, Murata K, Maeda T, Asahara Y, Kagawa Y. Yokoyama T, et al. Biol Pharm Bull. 2021;44(11):1767-1774. doi: 10.1248/bpb.b21-00535. Biol Pharm Bull. 2021. PMID: 34719653 Free article.
A correlation was observed between changes in pulse rate from the baseline and plasma concentrations of cilostazol (R = 0.539, p = 0.002), OPC-13015 (R = 0.396, p = 0.030) and OPC-13213 (R = 0.383, p = 0.037). A multiple regression model, consisting of factors of the plasm …
A correlation was observed between changes in pulse rate from the baseline and plasma concentrations of cilostazol (R = 0.539, p = 0.002), O …
94 results